cells Article Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse Tamara L. Paget 1 , Emma J. Parkinson-Lawrence 1, Paul J. Trim 2, Chiara Autilio 3, Madhuriben H. Panchal 4, Grielof Koster 4, Mercedes Echaide 3, Marten F. Snel 2, Anthony D. Postle 4, Janna L. Morrison 5,Jésus Pérez-Gil 3 and Sandra Orgeig 1,* 1 Mechanisms in Cell Biology and Disease Group, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia;
[email protected] (T.L.P.);
[email protected] (E.J.P.-L.) 2 Proteomics, Metabolomics and MS-Imaging Core Facility, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia;
[email protected] (P.J.T.);
[email protected] (M.F.S.) 3 Department of Biochemistry, Faculty of Biology and Research Institute Hospital 12 de Octubre (Imas12), Complutense University, 28003 Madrid, Spain;
[email protected] (C.A.);
[email protected] (M.E.);
[email protected] (J.P.-G.) 4 Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK;
[email protected] (M.H.P.);
[email protected] (G.K.);
[email protected] (A.D.P.) 5 Early Origins Adult Health Research Group, Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia;
[email protected] * Correspondence:
[email protected]; Tel.: +61-410-422-712 Citation: Paget, T.L.; Parkinson-Lawrence, E.J.; Trim, P.J.; Abstract: Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disease with significant Autilio, C.; Panchal, M.H.; Koster, G.; Echaide, M.; Snel, M.F.; Postle, A.D.; neurological and skeletal pathologies.